{"success":true,"data":{"pressRelease":{"id":"137602","rtpr_id":"nBw1VwVb6a-20260908","ticker":"CGC","exchange":"NASDAQ","all_tickers":["CGC","WEED"],"title":"Canopy Growth Broadens Australian Medical Cannabis Portfolio With New Formats and Formulations","author":"Business Wire","published_at":"2026-09-08T11:30:00.340Z","article_body":"Canopy Growth Broadens Australian Medical Cannabis Portfolio With New Formats\nand Formulations\n\nNew pastille and all-in-one vape formats, expanded oil and softgel offerings,\nand new flower SKUs build on international growth momentum\n\nCanopy Growth Corporation (“Canopy Growth”, “our”, “we” or the\n“Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed\nto bettering lives through cannabis, today announced a broadening of its\nmedical cannabis portfolio in Australia across its Spectrum Therapeutics,\nSpectrum Therapeutics Reserve, 7ACRES, Tweed and Twd. brands. The expansion\nintroduces two new product formats, and new formulations within its existing\noil and softgel ranges.\n\n“Expanding our product offering in established markets like Australia is\ncentral to our international medical strategy,” said Luc Mongeau, Chief\nExecutive Officer, Canopy Growth. “These new formats and formulations\nreflect the continued strength of our global supply chain and our ability to\nevolve our existing portfolio while bringing a broader range of high-quality\nproducts to international markets.”\n\nNew formats, now available\n\n\n * Pastilles – Canopy Growth’s first pastille format in Australia:\n\n\n* Tweed Red 10\n\n * Tweed Blue 10:10\n\n * Spectrum Triple Balance 10:10:10\n\n * Spectrum Dawn 1:10:5\n\n\n\n\n * All-in-one vapes – Canopy Growth’s first AIO vape format in Australia:\n\n\n* 7 ACRES Fondant Live Resin AIO Vape 1 mL (Indica)\n\n * Spectrum Therapeutics Reserve Berea Live Resin AIO Vape 1 mL (Sativa)\n\n\n\n\nExpanded formulations, now available\n\n\n * Oils – Canopy Growth’s first Australian oils to include CBG and CBN:\n\n\n* Spectrum Flow\n\n * Spectrum Sunset\n\n\n\n\n * Softgels – expanding the range beyond isolate based formulations:\n\n\n* Spectrum White 50\n\n * Spectrum Black 10\n\n\n\n\nAlso new to the portfolio\n\n\n * Flower:\n\n\n* Two new SKUs added under the Twd. value range\n\n\n\n\n“Prescribers and patients in Australia are asking for more choice in format\nand formulation,” said Andrew Bevan, President, Medical, Canopy Growth.\n“These launches give clinicians more options to tailor treatment approaches,\nwhile our new pastille and oil offerings reflect formulation work shaped by\ninsights from our Canadian clinic and provider network.”\n\nAbout Canopy Growth\n\nCanopy Growth is a leading global company committed to bettering lives through\ncannabis. With a focus on cultivation excellence, quality, trust, innovation\nand disciplined execution, Canopy Growth is a consumer-centric company serving\npatients, consumers and partners alike.\n\nThe Company’s portfolio of owned and licensed brands, including Tweed,\n7ACRES, DOJA, Deep Space, DeeLish, Claybourne, MTL Cannabis, Low Key by MTL\nand R’belle, as well as category-defining Storz & Bickel, delivers\ninnovative cannabis products to consumers across Canada and beyond. It is also\nCanada’s leading provider of medical cannabis services through Spectrum\nTherapeutics, Abba Medix, Apollo, and Canada House Clinics.\n\nThe Company also holds an unconsolidated, non-controlling interest in Canopy\nUSA, LLC, which provides exposure to the U.S. THC market.\n\nGuided by its commitment to leadership, excellence, trust and innovation,\nCanopy Growth is working to shape a future where the plant is trusted for its\nability to better lives.\n\nFor more information visit www.canopygrowth.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.canopygrowth.com%2F&esheet=54599985&newsitemid=20260908666726&lan=en-US&anchor=www.canopygrowth.com&index=1&md5=acfd9dfa2ce246d87c8bd89abbecabcf)\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260908666726/en/\n(https://www.businesswire.com/news/home/20260908666726/en/)\n\nMedia Contact: media@canopygrowth.com \n(mailto:media@canopygrowth.com) \nInvestor Contact: invest@canopygrowth.com (mailto:invest@canopygrowth.com)\n\n\nCopyright Business Wire 2026","article_body_html":"","raw_payload":{"data":{"id":"nBw1VwVb6a-20260908","title":"Canopy Growth Broadens Australian Medical Cannabis Portfolio With New Formats and Formulations","author":"Business Wire","ticker":"CGC","created":"2026-09-08T11:30:00.340Z","tickers":["CGC","WEED"],"exchange":"NASDAQ","article_body":"Canopy Growth Broadens Australian Medical Cannabis Portfolio With New Formats\nand Formulations\n\nNew pastille and all-in-one vape formats, expanded oil and softgel offerings,\nand new flower SKUs build on international growth momentum\n\nCanopy Growth Corporation (“Canopy Growth”, “our”, “we” or the\n“Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed\nto bettering lives through cannabis, today announced a broadening of its\nmedical cannabis portfolio in Australia across its Spectrum Therapeutics,\nSpectrum Therapeutics Reserve, 7ACRES, Tweed and Twd. brands. The expansion\nintroduces two new product formats, and new formulations within its existing\noil and softgel ranges.\n\n“Expanding our product offering in established markets like Australia is\ncentral to our international medical strategy,” said Luc Mongeau, Chief\nExecutive Officer, Canopy Growth. “These new formats and formulations\nreflect the continued strength of our global supply chain and our ability to\nevolve our existing portfolio while bringing a broader range of high-quality\nproducts to international markets.”\n\nNew formats, now available\n\n\n * Pastilles – Canopy Growth’s first pastille format in Australia:\n\n\n* Tweed Red 10\n\n * Tweed Blue 10:10\n\n * Spectrum Triple Balance 10:10:10\n\n * Spectrum Dawn 1:10:5\n\n\n\n\n * All-in-one vapes – Canopy Growth’s first AIO vape format in Australia:\n\n\n* 7 ACRES Fondant Live Resin AIO Vape 1 mL (Indica)\n\n * Spectrum Therapeutics Reserve Berea Live Resin AIO Vape 1 mL (Sativa)\n\n\n\n\nExpanded formulations, now available\n\n\n * Oils – Canopy Growth’s first Australian oils to include CBG and CBN:\n\n\n* Spectrum Flow\n\n * Spectrum Sunset\n\n\n\n\n * Softgels – expanding the range beyond isolate based formulations:\n\n\n* Spectrum White 50\n\n * Spectrum Black 10\n\n\n\n\nAlso new to the portfolio\n\n\n * Flower:\n\n\n* Two new SKUs added under the Twd. value range\n\n\n\n\n“Prescribers and patients in Australia are asking for more choice in format\nand formulation,” said Andrew Bevan, President, Medical, Canopy Growth.\n“These launches give clinicians more options to tailor treatment approaches,\nwhile our new pastille and oil offerings reflect formulation work shaped by\ninsights from our Canadian clinic and provider network.”\n\nAbout Canopy Growth\n\nCanopy Growth is a leading global company committed to bettering lives through\ncannabis. With a focus on cultivation excellence, quality, trust, innovation\nand disciplined execution, Canopy Growth is a consumer-centric company serving\npatients, consumers and partners alike.\n\nThe Company’s portfolio of owned and licensed brands, including Tweed,\n7ACRES, DOJA, Deep Space, DeeLish, Claybourne, MTL Cannabis, Low Key by MTL\nand R’belle, as well as category-defining Storz & Bickel, delivers\ninnovative cannabis products to consumers across Canada and beyond. It is also\nCanada’s leading provider of medical cannabis services through Spectrum\nTherapeutics, Abba Medix, Apollo, and Canada House Clinics.\n\nThe Company also holds an unconsolidated, non-controlling interest in Canopy\nUSA, LLC, which provides exposure to the U.S. THC market.\n\nGuided by its commitment to leadership, excellence, trust and innovation,\nCanopy Growth is working to shape a future where the plant is trusted for its\nability to better lives.\n\nFor more information visit www.canopygrowth.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.canopygrowth.com%2F&esheet=54599985&newsitemid=20260908666726&lan=en-US&anchor=www.canopygrowth.com&index=1&md5=acfd9dfa2ce246d87c8bd89abbecabcf)\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260908666726/en/\n(https://www.businesswire.com/news/home/20260908666726/en/)\n\nMedia Contact: media@canopygrowth.com \n(mailto:media@canopygrowth.com) \nInvestor Contact: invest@canopygrowth.com (mailto:invest@canopygrowth.com)\n\n\nCopyright Business Wire 2026"},"type":"article","timestamp":"2026-09-08T11:30:00.408336707Z","server_sent_at_ms":1788867000408},"received_at":"2026-09-08T11:30:00.505Z","source_url":"https://www.businesswire.com/news/home/20260908666726/en/"},"analysis":{"id":"126478","press_release_id":"137602","analysis_json":{"industry":{"label":"Pharmaceuticals","sector":"Health Care"},"redFlags":[],"eventType":"product_launch","narrative":"Canopy Growth broadened its Australian medical cannabis portfolio with two new product formats — pastilles and all-in-one vapes — plus expanded oil and softgel formulations and new flower SKUs across its Spectrum Therapeutics, Spectrum Therapeutics Reserve, 7ACRES, Tweed and Twd. brands.\n\nBoth the pastille and all-in-one vape formats are firsts for the company in Australia, and the new Spectrum Flow and Spectrum Sunset oils are its first Australian oils to include CBG and CBN.\n\nCEO Luc Mongeau called expansion in established markets like Australia central to the company's international medical strategy, citing global supply-chain strength, while President of Medical Andrew Bevan said the launches respond to prescriber and patient demand for more format and formulation choice.","sentiment":"bullish","agentHooks":{"shouldPost":false,"suggestedAngle":"Format breadth push in Australia underscores Canopy's international medical strategy, but no revenue or volume figures were attached — low immediate market impact."},"keyFigures":{"customDimensions":{"new_aio_vape_skus":2,"new_pastille_skus":4,"new_flower_skus_twd":2,"new_product_formats":2}},"quotedText":"central to our international medical strategy","namedEntities":{"people":[{"name":"Luc Mongeau","role":"Chief Executive Officer, Canopy Growth"},{"name":"Andrew Bevan","role":"President, Medical, Canopy Growth"}],"products":["Spectrum Therapeutics","Spectrum Therapeutics Reserve","7ACRES","Tweed","Twd.","Tweed Red 10","Tweed Blue 10:10","Spectrum Triple Balance 10:10:10","Spectrum Dawn 1:10:5","7ACRES Fondant Live Resin AIO Vape 1 mL","Spectrum Therapeutics Reserve Berea Live Resin AIO Vape 1 mL","Spectrum Flow","Spectrum Sunset","Spectrum White 50","Spectrum Black 10"],"companies":[{"name":"Canopy Growth Corporation","ticker":"CGC","relationship":"filer"},{"name":"Canopy USA, LLC","relationship":"unconsolidated, non-controlling interest"}],"dollarAmounts":[]},"materialImpact":{"score":2,"reasoning":"Issuer-authored portfolio expansion in Australia adds new pastille and all-in-one vape formats (both firsts for the company there) plus new oil, softgel and flower SKUs. It supports the international medical strategy but carries no financial figures or guidance, making it a routine, low-materiality launch."},"tickerRelevance":{"others":[{"ticker":"WEED","relevance":"same issuer — TSX listing"}],"primary":"CGC"},"globalImportance":20,"audienceRelevance":35,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid-cap international cannabis name","eventGravity":"routine product portfolio expansion","sectorWeight":"medical cannabis / consumer health","issuerAuthored":true,"financialDisclosure":"none — no revenue, guidance, or deal value stated","retailFavoriteBoost":true}},"event_type":"product_launch","event_type_secondary":null,"sentiment":"bullish","material_impact_score":2,"narrative":"Canopy Growth broadened its Australian medical cannabis portfolio with two new product formats — pastilles and all-in-one vapes — plus expanded oil and softgel formulations and new flower SKUs across its Spectrum Therapeutics, Spectrum Therapeutics Reserve, 7ACRES, Tweed and Twd. brands.\n\nBoth the pastille and all-in-one vape formats are firsts for the company in Australia, and the new Spectrum Flow and Spectrum Sunset oils are its first Australian oils to include CBG and CBN.\n\nCEO Luc Mongeau called expansion in established markets like Australia central to the company's international medical strategy, citing global supply-chain strength, while President of Medical Andrew Bevan said the launches respond to prescriber and patient demand for more format and formulation choice.","key_figures":{"customDimensions":{"new_aio_vape_skus":2,"new_pastille_skus":4,"new_flower_skus_twd":2,"new_product_formats":2}},"named_entities":{"people":[{"name":"Luc Mongeau","role":"Chief Executive Officer, Canopy Growth"},{"name":"Andrew Bevan","role":"President, Medical, Canopy Growth"}],"products":["Spectrum Therapeutics","Spectrum Therapeutics Reserve","7ACRES","Tweed","Twd.","Tweed Red 10","Tweed Blue 10:10","Spectrum Triple Balance 10:10:10","Spectrum Dawn 1:10:5","7ACRES Fondant Live Resin AIO Vape 1 mL","Spectrum Therapeutics Reserve Berea Live Resin AIO Vape 1 mL","Spectrum Flow","Spectrum Sunset","Spectrum White 50","Spectrum Black 10"],"companies":[{"name":"Canopy Growth Corporation","ticker":"CGC","relationship":"filer"},{"name":"Canopy USA, LLC","relationship":"unconsolidated, non-controlling interest"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-08T11:39:00.705Z","global_importance":20,"audience_relevance":35,"importance_components":{"tickerTier":"mid-cap international cannabis name","eventGravity":"routine product portfolio expansion","sectorWeight":"medical cannabis / consumer health","issuerAuthored":true,"financialDisclosure":"none — no revenue, guidance, or deal value stated","retailFavoriteBoost":true}},"durationMs":87852,"modelName":"glm-4.7"}}